Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.16    -0.28 (-1.44%)
Bid:
19.02
Ask:
19.54
Spread: 0.52 (2.734%)
Market Cap: £49.22m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Director/PDMR Shareholding

30 Aug 2024 15:15

RNS Number : 3799C
Watkin Jones plc
30 August 2024
 

30 August 2024

 

Watkin Jones plc

('Watkin Jones' or the 'Company')

 

Director/PDMR Shareholding

 

Watkin Jones plc (AIM:WJG) announces that on 30 August 2024, the following nominal-cost share award over ordinary shares of 1 penny each in the Company was granted under the Watkin Jones Long Term Incentive Plan 2018 to the following person discharging managerial responsibilities ('Award'):

 

PDMR

 

Position

Number of shares granted under the Award 

Total number of shares subject to outstanding LTIP Awards

Simon Jones

Chief Financial Officer

1,531,728

1,531,728

 

The Award has a nominal exercise price of one penny per share and normally becomes exercisable from 21 May 2027, subject to continued employment and performance based on total shareholder return ('TSR') measured against absolute growth targets.

 

The absolute TSR targets and underlying three year performance period are the same as attached to the LTIP Awards granted to others earlier to this year on 30 January 2024 as previously disclosed. The number of shares under the Award granted to Mr Jones was also calculated by reference to the same reference share price as was used for the January 2024 LTIP Awards (being the Watkin Jones average share price from 1 October 2023 to 29 January 2024).

 

In addition to assessing performance against the TSR targets, the Remuneration Committee retains discretion to reduce the vesting of the Award to ensure that all relevant factors are taken into account, including the consideration of any windfall gains.

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Simon Jones

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Watkin Jones plc

b)

LEI

2138009X19O21NU5SG79

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.01 each

 

ISIN: GB00BD6RF223

b)

Nature of the transaction

Grant of Award under the Watkin Jones Long Term Incentive Plan 2018

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

1,531,728

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

30 August 2024

f)

Place of the transaction

Outside of a trading venue

 

- Ends -

 

For further information:

 

Watkin Jones plc

 

Alex Pease, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Simon Jones, Chief Financial Officer

www.watkinjonesplc.com

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

Jefferies Hoare Govett (Joint Corporate Broker)

 

Tel: +44 (0) 20 7029 8000

James Umbers / Paul Bundred

 

www.jefferies.com

 

Media enquiries:

Burson Buchanan

 

Henry Harrison-Topham / Steph Whitmore

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.bursonbuchanan.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDLFLSELSEFA
Date   Source Headline
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.